ライフサイエンスコーパス: age group

1 female patients (15% lower for women in same age group).

2 6.8 per 100 000 among all women in the same age group.

3 counting for 35% (7/20) of all cases in this age group.

4 number of diagnoses that are unique to this age group.

5 tes of unintended pregnancies than any other age group.

6 ng to number of vaccine doses, duration, and age group.

7 also significantly larger for the 9-25 week age group.

8 90% of those living with HIV by 2020 in this age group.

9 substantial effect on disease burden in this age group.

10 fidence intervals controlling for season and age group.

11 so suggests a greater disease burden in this age group.

12 ibutor to TDF-associated BMD decline in this age group.

13 rage requirement (EAR) is available for this age group.

14 -hospital deaths among African cases in this age group.

15 younger than 5 years by admission month and age group.

16 is, however, was only observed in the p30-60 age group.

17 ivery, which already is common in this older age group.

18 f infants with HAI titers of 1:40 or more by age group.

19 rage was assessed by geographical region and age group.

20 ons of TBI mortality with location, sex, and age group.

21 as increased as an indication for LT in this age group.

22 1000 (CI, 8.6 to 11.1) in the 75- to 79-year age group.

23 ce Test, normed within the sample by 6-month age groups.

24 leading category of road user for the other age groups.

25 Randomization was stratified by gestational age groups.

26 nal influenza transmission in younger (0-14) age groups.

27 ival improvement in AYAs compared with other age groups.

28 showed a marginal difference between the two age groups.

29 cross all population percentiles for several age groups.

30 rior prefrontal cortex across WM domains and age groups.

31 aceted interventions to prevent falls in all age groups.

32 cine guidelines in the newborn and pediatric age groups.

33 IRs were highest among males in all age groups.

34 An A(H7N9) pLAIV candidate was safe in both age groups.

35 to an overall increase in incidence in older age groups.

36 o 45-year, 46- to 60-year and 61- to 75-year age groups.

37 ransplantation compared to older and younger age groups.

38 tic-nonsusceptible IPD decreased in multiple age groups.

39 to blunting, incidence increases among older age groups.

40 k of stroke and death within narrow (5 year) age groups.

41 in the early childhood, 20-24 and 35-39 year age groups.

42 mmunological endpoints did not differ across age groups.

43 mptomatic respiratory tract infection in all age groups.

44 es are under development to target different age groups.

45 n between gender and survival varies between age groups.

46 ined to </=1 case per 100 000 persons in all age groups.

47 ower among young men and women than in older age groups.

48 se trends were driven primarily by the older age groups.

49 ality and duration of hospitalization in all age groups.

50 hacin) synthesis increased CGRP EC50 in both age groups.

51 treatment reduced antibody responses in both age groups.

52 EMR-RFA over esophagectomy persists for all age groups.

53 s, and 14 (12 to 17) for the 13-24 wk infant age groups.

54 patterns carry over into infancy and toddler age groups.

55 ntry, and we applied minimisation by sex and age groups.

56 y reported with TDV than with placebo in all age groups.

57 MUNO and MUO subjects in both sexes and all age groups.

58 9 to 4.7% in 2015) students overall, and all age groups.

59 gers were uniquely associated with different age groups.

60 ure, and persist across both child and adult age groups.

61 e most favorable GI safety profile among all age groups.

62 ric choice, adult choice, or choice for both age groups.

63 nce of T2D has increased dramatically in all age groups.

64 nsidered when assessing vaccination of older age groups.

65 cores decreased in both sexes and across all age groups.

66 r-visit and total costs increased across all age groups.

67 cause of neurological disability across all age groups.

68 ted adverse events in this period across all age groups.

69 using questionnaires developed for different age groups.

70 dult choice, and 975,818 for choice for both age groups.

71 Strong age-assortativity was observed in all age groups.

72 rms, the risk increase was larger in younger age groups.

73 For cancer diagnosed in children in age groups 0-14 years and 15-19 years, the odds ratios f

74 thod to give a lower estimate in the younger age group (0.7% vs 0.8%), suggesting that it was the onl

75 rtality was 3.4% in neonates and 0.6% in all age groups (0-18 years).

76 pecific incidence rates (ASR) for individual age groups (0-4 years, 5-9 years, 10-14 years, and 15-19

77 ther than 16 and 18 remained the same across age groups: 16.8% (95% confidence interval, 12.6%-21.9%)

78 ble logistic regression models stratified by age group (18 to 64 and >/= 65 years).

79 Healthy subjects in 2 age groups (18-49 years and 50-70 years) with undetectab

80 Of 3775 SCAs in all age groups, 186 (5%) occurred in the young (mean age 25.

81 used the proportion of women in each 5-year age group (25-29 years to 75-79 years) and 5-year period

82 ranging in age between 30 and 94 years (four age groups: 30's, 50's, 70's, 90's) were measured in one

83 Forty-five children (90 eyes) in the age group 4-16 years: subjects with unilateral congenita

84 r elevated prostate-specific antigen levels (age groups: 41-50 years, 51-60 years, and 61-70 years).

85 rted pertussis cases in 2012 for children in age groups 5 years and younger and 10 to 14 years.

86 hrough home telephone lists, were matched by age group (+/-5 years), county, and month of hospitaliza

87 triennial versus biennial screening for both age groups (50 to 74 years, median of 3.4 to 5.1 vs. 4.1

88 DCIS combined increased significantly across age groups (50-54 years, detection rate of 1.15 per thou

89 sent study, the majority of patients were in age group 56-65 years, 56% were males and 44% were femal

90 devices were implanted in the 65- to 84-year age group (64.6%), with significant increase in number o

91 residence (rural/urban), gender, and 5-year age-group (65+) in 1987-2014 were provided by the Chines

92 In comparable age groups (9 to 12 years and 13 to 16 years), the burde

93 Similar reductions were found across all age groups, across multiple sensitivity analyses, and wh

94 lower risk of delays between refills in all age groups (adjusted relative risk, 0.54; 95% CI, 0.32 t

95 rtions of reported barriers to adherence per age group (adults, adolescents, and children).

96 We compared type-specific results by age group against those from a baseline 2005 Australian

97 maternal malnutrition affecting the younger age groups (aged 28 days to 4 years), whereas high bodyw

98 across all outcomes compared to the youngest age group (ages 0-4 y).

99 lenvatinib treatment versus placebo in both age groups, although higher toxicity was observed in old

100 duals (CI, 4.4 to 6.8) in the 70- to 74-year age group and 10.3 per 1000 (CI, 8.6 to 11.1) in the 75-

101 tified shortfalls in mortality reductions by age group and cause, and forecasted life expectancy path

102 Similar findings were apparent by age group and physician type.

103 the proportions in each dependency state (by age group and sex) were applied to the 2014 UK [correcte

104 Separately for each age group and sex, DNA samples representing the highest

105 In each age group and sex, the pulmonary tuberculosis prevalence

106 calculated for above diagnoses separated by age group and sex.

107 lly to document facilities and park users by age group and sex.

108 contributed to symptomatic disease varied by age group and specific virus.

109 asal cell carcinoma (BCC) are common in this age group and treatment is often challenging in this pop

110 the effects of heat on morbidity across all age groups and across a wider range of temperatures.

111 ence of HZ significantly increased among all age groups and both sexes.

112 are well established for these two different age groups and diseases, a grey area exists with regard

113 wing an SSO event, with positive ORs for all age groups and for three of the four counties.

114 baseline model was adjusted for alternative age groups and high-risk dysplastic variants.

115 Vaccine effectiveness (VE) across age groups and vaccine types was examined among outpatie

116 sex differences were greatest in the younger age groups and were attenuated by accounting for differe

117 transplantation among patients in different age groups and with different degrees of comorbidity sco

118 preferential mixing of close contacts within age groups and within sexes.

119 eed for improvement was present in the young age-group and for older subjects with increasing age.

120 zed sequentially, starting with the youngest age group, and allowing the interval of screening to cha

121 19 geographical areas or ethnicities by sex, age group, and cancer type.

122 However, it can develop in any age group, and the prevalence is increasing even in the

123 r of driver license application, sex, 5-year age groups, and 3 body mass index categories.

124 ere ranked by their 30-day RSMRs for these 3 age groups, and agreement in rankings was plotted.

125 pread across regions, urban and rural areas, age groups, and cause-of-death categories, but great dis

126 ergent eye-related ED visits among different age groups, and independent factors associated with emer

127 er than male-to-male sexual contact, younger age groups, and persons with gaps in care had higher vir

128 ct of the vaccine in the 2-4 years and older age groups, and to monitor serotype replacement.

129 Most CRCs in this age group are known to arise in the distal colon and rec

130 All age groups are affected with rapidly growing importance

131 ough biotic and abiotic degradation, and all age groups are exposed not only to BDE-209 and -99 but a

132 Controversy persists regarding which age groups are most affected, leading to uncertainty abo

133 studies of the etiology of PID in different age groups are required.

134 ually, with prespecified analyses by 10-year age group based on age at time of randomization.

135 into 21 world regions, in both sexes and 20 age groups, between 1990 and 2015.

136 Additionally, for comparable age groups, both male and female brains scale in exactly

137 fference in risk of graft failure across all age groups, both younger and older age groups had signif

138 l identifies distinct sets of rules for each age group by using Boolean operators to describe the com

139 sits, diagnostic tests, and prescriptions by age group (children 1-17 years, adults 18-64 years) usin

140 ciated with HPV 16/18 was significant in all age groups combined (90.5%, 96.2% CI 78.6-96.5).

141 ium for African Americans in the 18-49 years age group compared with Caucasians of similar age was 0.

142 (OR, 1.93 [95% CI, 1.07-3.47]); and younger age groups compared with age >/=36 years (OR, 1.83 [95%

143 When examined by 10-year age groups comparing younger women (aged 50-59 years) to

144 ely low numbers of person-years, the highest age groups contributed most to the increasing trend.

145 May 2015, the population was divided into 9 age groups corresponding to the current pertussis vaccin

146 In this age group, CPM proportions for the period from 2010 to 2

147 Across age groups, cytomegalovirus seropositive individuals dis

148 w much the proportions of fish in the oldest age groups declined over time.

149 , with the rotavirus positivity rate in this age group declining from 40.9% in prevaccine years to 34

150 S detection rates were determined for 5-year age groups (detection rates per 1000 women screened) to

151 In this age group, differences were present between participants

152 successful in assessing HH information for 2 age groups, documenting written vaccination history for

153 r care should be taken in the 30-50-year-old age group, due to their significantly increased risk of

154 lted in reduced vaccine effectiveness in all age groups during the 2014-2015 influenza season.

155 Hearing loss is common in all age groups, even in young adults and adolescents.

156 evalences were similar for gender across all age groups except for late AMD in the oldest age categor

157 the predominant finding among persons in all age groups, except for those 31 to 35 years of age, for

158 s have recently been shown in the adolescent age group, following earlier descriptions of a rise in c

159 and the differences were greatest in younger age groups (for example, women aged 18-34 years and >/=7

160 esult did not hold for the full 0- to 1-year age group, for whom antenatal vaccination did not reduce

161 data on the pertussis disease burden in this age group from low- and lower-middle-income countries, i

162 The primary data were gathered into 5-year age groups from 0 to >/=100, in urban or rural populatio

163 d for pedestrians and motorcyclists in all 7 age groups from 2006 to 2013.

164 er of asymptomatic monoinfections across all age groups; further work is needed to estimate prevalenc

165 Suicidal behaviour differs between sexes, age groups, geographic regions, and sociopolitical setti

166 ed >/=80 years) are the most rapidly growing age group globally, and are most in need of health care

167 20-24 years, those born to mothers in older age groups had a 13%-36% higher risk of pediatric cancer

168 cross all age groups, both younger and older age groups had significantly lower risk of posttransplan

169 h improved survival, the youngest and oldest age groups had similarly poor outcomes even when a targe

170 mothers with GDM or without GDM (matched on age group, health region, and year of delivery) who had

171 s with preexcitation when looking across all age groups (HR, 1.07; 95% CI, 0.68-1.68).

172 over interference across chromosome, sex and age groups, identified associated candidate genes, and p

173 We recalibrated risk scores for each sex and age group in each country using country-specific mean ri

174 dence of an increased periprocedural risk by age group in the CEA group (p=0.34).

175 avoidable hospital admissions (PAH) in this age group in the USA.

176 or analyzing inequality in mortality for all age groups in 1990, 2000, and 2010.

177 xpected to be cost saving in contacts of all age groups in areas with malaria parasite prevalence in

178 nsultations or hospitalizations according to age groups in England in the period July 2007-June 2013.

179 mortality decreased substantially across all age groups in Hispanic individuals (up to 3.2% per year)

180 l episode rates in allergy by sex and across age groups in order to understand whether and how the he

181 remarkably high, ranging from 11%-26% across age groups in Pittsburgh to 38%-53% in Los Angeles.

182 seasonal influenza epidemics among different age groups in Queensland, Australia.

183 evel were relatively small for older (>/=65) age groups in Queensland, Australia.

184 ignificant differences were observed between age groups in terms of gastro-intestinal and extra-intes

185 assessed rates of stroke or death in 5-year age groups in the periprocedural period (between randomi

186 stimates of the prevalence of CHD across all age groups in the United States.

187 of caudal regression syndrome in 4 different age groups including fetus, infant, early childhood and

188 s of caudal regression syndrome in different age groups including prenatal, infant and adult.

189 ncreased significantly over 12 months in all age groups, including in 5- to 6.9-year-old boys.

190 t protection afforded by PCV in unvaccinated age groups, including those in high-HIV-prevalence setti

191 country-specific burden of stroke by sex and age groups, including trends in stroke burden from 1990

192 uired RV infections by 89.3% was seen in all age groups, including unvaccinated neonates and young in

193 -55%, 32%) and similarly ineffective between age groups; increased risk of infection was not observed

194 ctions in symptomatic pertussis incidence by age group, increases in wP vaccine-related adverse effec

195 g the effect of diet on relapse rate in this age group is likely to provide more robust answers.

196 The optimal choice for AVR in each age group is not clear.

197 A linear model estimated at the age-group level implies that the Internet explains a sma

198 rlying airway inflammation of asthma in this age group likely differs from younger patients and is fe

199 mortality, and mortality differences by sex, age group, location (urban/rural), and external cause of

200 ortion of children with enteric fever in the age groups <5 years, 5-9 years, and 10-14 years.

201 tory illnesses and positive for influenza by age group (<6 mo, <1 y, <2 y, <5 y, 5-17 y, and <18 y).

202 io-Economic Advantage and Disadvantage for 3 age groups (<15, 15-64, and >/=65 years).

203 ries into three analytic divisions for three age groups (<65 years, 65-74 years, and >/=75 years) usi

204 n seropositive for every HPV type across all age groups, many statistically significant.

205 Mortality declines aggregated across all age groups mask uneven gains across health disorders.

206 ted rise in food-induced anaphylaxis in this age group may reflect an increasing prevalence of food a

207 the anterior frontal structures in the older age group may reflect developmental consolidation of the

208 rates among children and to people in other age groups, may rise following attenuated influenza infe

209 etes and CVD events occurred in the youngest age group modeled (35-44 y).

210 ortality decline occurred in the 1-59 months age group; neonatal mortality declined more slowly (from

211 owever, the downstream increase in the older age groups occurs with a delay of approximately a decade

212 opositivity (25/155) was observed within the age group of 10 to 14 years.

213 SUBJECT AND Women in the age group of 16-50 years with an admission diagnosis or

214 The highest number of patients was in the age group of 51-60 years (32%).

215 Age groups of 25-34 (P = 0.017) and 15-24 years (P = 0.0

216 Age groups of animals were performed.

217 and dentin mineralization using 3 different age groups of DSPP-null and wild-type mice.

218 revalence appears to be widespread among all age groups of men, and the HPV vaccination coverage is l

219 Patients were stratified into different age groups on the basis of valve position (aortic vs. mi

220 vestigate whether these associations vary by age group or sex.

221 vestigate whether these associations vary by age group or sex.

222 ars, but most risks were also significant in age group over 79 years.

223 ignificant interaction between treatment and age group (p=0.0379), showing that anastrozole is superi

224 es with uveitis than in control eyes for all age groups (P </= 0.01 for four of six 10-year age inter

225 RD was highest among persons in the youngest age group, particularly among young blacks.

226 clearly demonstrate differences in these two age groups, particularly in the innate immune responses.

227 ith pertussis-negative African cases in this age group, pertussis-positive cases were younger, more l

228 In this age group, poisonings from heroin increased from 0.96 (9

229 significant for donors in the >40 to 50 year age group (Ps < 0.008).

230 activation in the LV-wall adhesions between age-grouped PV-KO and wild-type mice, suggesting a delay

231 In the 12-23 month age group, radiological pneumonia decreased from 15.3 to

232 169-275 per 100000) compared with all other age groups (range, 15-150 per 100000; P < .001).

233 eveloped in 58%, and 66% of children in this age group received antibiotics.

234 cess cases (included 156 cases) affected all age groups regardless gender predilection.

235 bility on seasonal influenza among different age groups remain unclear.

236 LSG is evidently safe and effective in this age group, resulting in significant weight loss, improve

237 ince menopause onset (<10 years) rather than age group, results were nonsignificant and concordant fo

238 Comparisons of consecutively older age groups revealed that the prevalence of quadrivalent

239 is of particular concern because use by this age group seems to be associated with an increased likel

240 iasis diagnosis were individually matched on age group, sex, and enrollment length in months to 5 per

241 1999 and 2014 in people aged 25-64 years by age group, sex, and race and ethnicity, and to identify

242 enteric illness cases, matched according to age group, sex, and state of residence.

243 The relationships of age group, sex, and year of anaphylaxis with incidence r

244 Deaths were tabulated by age group, sex, census tract, and cause of death.

245 , analyses included interactions of ECT with age group, sex, race/ethnicity, and diagnosis group.

246 t benefit in decreasing IBTR across all DCIS age groups, similar to that seen in patients with invasi

247 nt-related index injury after adjustment for age group, socioeconomic status, and chronic conditions.

248 umin level attenuated sex differences in the age group-specific hospitalization and 30-day readmissio

249 Age group-specific hospitalization rates were consistent

250 We consider 5 separate methods of estimating age-group-specific population excess fractions (PEFs) of

251 age and were highest for the choice-for-both-age-groups strategy; adult choice also reduced cases in

252 umulative incidence of bleeding and, in some age groups, stroke than did recipients of a biologic pro

253 on investment, high-risk groups of the three age group subpopulations can be prioritized for vaccinat

254 SLC is unexpectedly poor compared with other age groups, suggesting more aggressive disease biology.

255 Generational analysis showed that older age groups tended to show smaller changes than younger a

256 At all other age groups tested, mGluR-LTD was almost identical betwee

257 By providing PrEP to 30% of MSM to the age group that account for 90% of local HIV incident cas

258 differences were observed in survival among age groups (the 95% CIs of hazard ratios included 1 for

259 For both age groups, the curvature discrimination thresholds obta

260 Between the youngest and oldest age groups, the number of nonsclerotic glomeruli decreas

261 When examined by 10-year age groups, the prevalence of early AMD ranged from 5.8%

262 tended to show smaller changes than younger age groups: the yearly score change in "chocolate and sw

263 For all age groups, there was an increase from 2006 to 2013 in o

264 mortality than the general population in all age groups through age 65.

265 % in 14-19 year olds and was higher in older age groups, through ages 25-29 years, and then similar t

266 In both age groups, TLR-2 costimulation elicited activation of n

267 We generated distinct sets of rules for each age group to capture the temporal differences seen in th

268 ed the thickness of myotubes (MTT) from both age groups to a similar extent.

269 rotocol for chest CT imaging in the youngest age group, together with a pictorial review of congenita

270 tussis rates were comparable among all other age groups until the late 2000s, when an increased burde

271 ncidence of M. tuberculosis infection in all age groups using these contact patterns, as well as the

272 accine effectiveness depends strongly on the age group vaccinated and local transmission intensity.

273 Compared to other age groups, VE against A(H1N1)pdm09 was lower for adults

274 Commonest age group was 50-69 yrs.

275 in hospital AMI achievement scores for each age group was also calculated using the Hospital Value-B

276 res and GABA were not correlated when either age group was considered separately.

277 Latin American cohort; no trend according to age group was observed.

278 Interaction by age group was only significant for the 250-mug patch (P

279 cost-effectiveness analysis, choice for both age groups was dominant when choice increased vaccine co

280 a (confirmed and unconfirmed) in these older age groups was reduced by 29% (95% CI 21%-35%, p < 0.001

281 s difference in modes of death between the 2 age groups was statistically significant (P=0.01).

282 tivariate analysis, risk group, subtype, and age group were independently associated with clustering

283 Differences in VE by age group were not significant.

284 rson-years for the 0-14 years and 0-19 years age groups were age-adjusted using the world standard po

285 Differences between age groups were determined with one-way analysis of vari

286 ons of age-standardised DALYs between the 20 age groups were observed in southeast Asia (60.1), Ocean

287 contents in the vegetarian meals for all the age groups were similar, in contrast, when compared to t

288 The remaining pigs ("aged" groups) were allowed to incubate for up to 73 mont

289 maller occurrence of disease in the youngest age group, whereas in Asia the picture was more mixed wi

290 Two age groups with an equal sex ratio were examined: those

291 e infected male and female mice of different age groups with SARS-CoV and analyzed their susceptibili

292 ), non-Hispanic whites (48% to 64%), and all age groups with the exception of persons aged 18-29 year

293 s of blindness and vision impairment in this age group, with a low prevalence of cataract (<22% for b

294 es of obesity and metabolic syndrome in this age group, with unhealthy lifestyle also playing an inde

295 s of the best-fitting model differed between age groups, with adolescents showing more conservative u

296 inib versus placebo in the younger and older age groups, with median PFS of 20.2 versus 3.2 months (h

297 ction and AGE in vaccinated and unvaccinated age groups within 1 year of introducing an infant rotavi

298 t upper and lower respiratory disease in all age groups worldwide.

299 Analysis by age groups yielded similar results.

300 uding a focus on key issues for two specific age groups-younger children (aged </=6 years) and adoles